Eila Suvanto‐Luukkonen

990 total citations
13 papers, 623 citations indexed

About

Eila Suvanto‐Luukkonen is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Reproductive Medicine. According to data from OpenAlex, Eila Suvanto‐Luukkonen has authored 13 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Genetics and 5 papers in Reproductive Medicine. Recurrent topics in Eila Suvanto‐Luukkonen's work include Menopause: Health Impacts and Treatments (5 papers), Estrogen and related hormone effects (4 papers) and Ovarian function and disorders (2 papers). Eila Suvanto‐Luukkonen is often cited by papers focused on Menopause: Health Impacts and Treatments (5 papers), Estrogen and related hormone effects (4 papers) and Ovarian function and disorders (2 papers). Eila Suvanto‐Luukkonen collaborates with scholars based in Finland, United Kingdom and United States. Eila Suvanto‐Luukkonen's co-authors include Antti Kauppila, Aimo Ruokonen, Aini Bloigu, Tuija Männistö, Heljä‐Marja Surcel, Marjo‐Riitta Järvelin, Anneli Pouta, Marja Vääräsmäki, Anna‐Liisa Hartikainen and Jorma Penttinen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Fertility and Sterility and Clinica Chimica Acta.

In The Last Decade

Eila Suvanto‐Luukkonen

13 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eila Suvanto‐Luukkonen Finland	10	399	182	137	115	102	13	623
Larry R. Laufer United States	10	349 0.9×	237 1.3×	35 0.3×	339 2.9×	110 1.1×	13	751
Judd Hl United States	10	231 0.6×	222 1.2×	73 0.5×	107 0.9×	66 0.6×	15	508
JoAnn V. Pinkerton United States	9	640 1.6×	462 2.5×	64 0.5×	164 1.4×	229 2.2×	12	954
Inger Øverlie Norway	8	182 0.5×	101 0.6×	41 0.3×	80 0.7×	50 0.5×	9	371
Robert W. Lash United States	12	471 1.2×	225 1.2×	175 1.3×	77 0.7×	34 0.3×	24	802
M. Gambacciani Italy	12	163 0.4×	101 0.6×	31 0.2×	49 0.4×	84 0.8×	19	468
J A Romijn Netherlands	10	386 1.0×	68 0.4×	40 0.3×	252 2.2×	14 0.1×	19	763
H T Chao Taiwan	12	179 0.4×	152 0.8×	153 1.1×	237 2.1×	76 0.7×	26	653
Muzaffer Temür Türkiye	11	126 0.3×	31 0.2×	91 0.7×	107 0.9×	31 0.3×	46	398
Wendy J. Brickman United States	15	124 0.3×	141 0.8×	13 0.1×	53 0.5×	22 0.2×	35	562

Countries citing papers authored by Eila Suvanto‐Luukkonen

Since Specialization

Citations

This map shows the geographic impact of Eila Suvanto‐Luukkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eila Suvanto‐Luukkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eila Suvanto‐Luukkonen more than expected).

Fields of papers citing papers by Eila Suvanto‐Luukkonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eila Suvanto‐Luukkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eila Suvanto‐Luukkonen. The network helps show where Eila Suvanto‐Luukkonen may publish in the future.

Co-authorship network of co-authors of Eila Suvanto‐Luukkonen

This figure shows the co-authorship network connecting the top 25 collaborators of Eila Suvanto‐Luukkonen. A scholar is included among the top collaborators of Eila Suvanto‐Luukkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eila Suvanto‐Luukkonen. Eila Suvanto‐Luukkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Männistö, Tuija, Marja Vääräsmäki, Anneli Pouta, et al.. (2008). Perinatal Outcome of Children Born to Mothers with Thyroid Dysfunction or Antibodies: A Prospective Population-Based Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 94(3). 772–779. 210 indexed citations

Suvanto‐Luukkonen, Eila, et al.. (2005). Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause The Journal of The North American Menopause Society. 12(1). 18–26. 144 indexed citations

Santala, Markku, et al.. (2001). Hyperprolactinemia Complicating Juveline Granulosa Cell Tumor of the Ovary. Gynecologic Oncology. 82(2). 389–391. 6 indexed citations

Suvanto‐Luukkonen, Eila & Antti Kauppila. (1999). The levonorgestrel intrauterine system in menopausal hormone replacement therapy: five-year experience. Fertility and Sterility. 72(1). 161–163. 42 indexed citations

Suvanto‐Luukkonen, Eila, et al.. (1998). Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel‐releasing intrauterine device or natural progesterone. Acta Obstetricia Et Gynecologica Scandinavica. 77(7). 758–763. 15 indexed citations

Suvanto‐Luukkonen, Eila, Helena Sundström, Jorma Penttinen, & Antti Kauppila. (1998). Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol. Archives of Gynecology and Obstetrics. 261(4). 201–208. 7 indexed citations

Suvanto‐Luukkonen, Eila, et al.. (1998). Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone. Acta Obstetricia Et Gynecologica Scandinavica. 77(7). 758–763. 11 indexed citations

Haapasaari, Kirsi‐Maria, Tytti Raudaskoski, Matti Kallioinen, et al.. (1997). Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. Maturitas. 27(2). 153–162. 55 indexed citations

Suvanto‐Luukkonen, Eila, Leila Risteli, Helena Sundström, et al.. (1997). Comparison of three serum assays for bone collagen formation during postmenopausal estrogen–progestin therapy. Clinica Chimica Acta. 266(2). 105–116. 26 indexed citations

10.

Suvanto‐Luukkonen, Eila, et al.. (1997). Percutaneous estradiol gel with an intrauterine levonorgestrel releasing device or natural progesterone in hormone replacement therapy. Maturitas. 26(3). 211–217. 28 indexed citations

11.

Lindholm, Päivi, Erkki Vilkman, Tytti Raudaskoski, Eila Suvanto‐Luukkonen, & Antti Kauppila. (1997). The effect of postmenopause and postmenopausal HRT on measured voice values and vocal symptoms. Maturitas. 28(1). 47–53. 51 indexed citations

12.

Suvanto‐Luukkonen, Eila, Helena Sundström, Jorma Penttinen, & Pentti Jouppila. (1997). Hydatidiform mole co‐existent with a live fetus. Acta Obstetricia Et Gynecologica Scandinavica. 76(4). 380–381. 1 indexed citations

13.

Suvanto‐Luukkonen, Eila, Helena Sundström, Jorma Penttinen, Antti Kauppila, & Eeva‐Marja Rutanen. (1995). Insulin-like growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy. Maturitas. 22(3). 255–262. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact